Interleukin-2 and Pembrolizumab for Metastatic Kidney Cancer
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
University of Alabama at Birmingham
University of Waterloo
University of Michigan
Columbia University
Stanford University
M.D. Anderson Cancer Center